-Mr. Barrow previously served as interim Chief Executive Officer and Chief Development Officer of MindMed -Carol Vallone appointed as Chair of the Board of Directors, Andreas Krebs appointed as Vice Chair and Perry Dellelce transitions from his role as Chairman- NEW YORK, Dec. 14, 2021 /CNW/ — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the “Company”)…


Previous articleatai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Index
Next articlePT277 – Ryan Zurrer – Venture Capital, Reciprocity, and the Regenerative Financing Vine